Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2020-04-08 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
109年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no voting results, no legal or regulatory announcements, and no mention of any report publication. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing. The document length is very short (601 characters), and it is a straightforward compliance disclosure without substantive financial data or analysis. Therefore, it fits best under Regulatory Filings (RNS).
2020-04-08 Chinese
109年3月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of net operating revenue for a company named 科妍 for the period 民國109年03月 (March 2020). It contains financial figures comparing current month and year-to-date revenue against the previous year, with percentage changes and notes on accounting standards (IFRS). The document is very short (764 characters) and appears to be a brief financial summary rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It also does not fit other categories like earnings release or management discussion. Given the brevity and nature, it is best classified as a Fund Information / Factsheet (FS), which is a brief summary of key financial facts.
2020-04-08 Chinese
109年03月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, managers, and their family members. It shows changes in shareholdings, types of shares held, and related notes. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a report publication, earnings release, or regulatory certification. The document is a detailed insider shareholding disclosure, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions by company directors and executives. The document length is sufficient and contains substantive data on insider holdings and changes, confirming it is not a mere announcement or summary. Therefore, the appropriate classification is DIRS.
2020-04-06 Chinese
109年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings and pledged shares of company insiders, including directors, supervisors, and managers. It lists their current holdings, pledged shares, and related ratios. The content is focused on insider shareholdings and does not include financial statements, earnings data, or management discussion. It is a typical insider shareholding disclosure, which corresponds to notifications about directors' dealings or insider share transactions. Given the nature of the data, the most appropriate classification is Director's Dealing (DIRS). The document length is short and it is not an announcement of a report or a certification, so it is not RNS or RPA.
2020-04-06 Chinese
108年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory limits as per the Ministry of Economic Affairs Investment Commission. The document length is short (1291 characters) and it does not appear to be an announcement of a report publication but rather a regulatory disclosure of investment information. It does not contain full financial statements or comprehensive financial performance data typical of annual or interim reports. It is a regulatory disclosure related to investment activities, fitting best under Regulatory Filings (RNS) as it does not match other more specific categories like Annual Report, Interim Report, or Capital/Financing Update.
2020-03-25 Chinese
公告本公司董事會決議盈餘增資發行新股
Capital/Financing Update Classification · 95% confidence The document is a company announcement from the board of directors regarding a decision to increase capital by issuing new shares from retained earnings. It includes details such as the number of shares issued, par value, total amount, and rights attached to the new shares. This is a clear update on the company's capital structure and financing activities. The document length is short (820 characters) but contains substantive information about the capital increase, not just a notice of report publication or a certification. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-03-24 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.